Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Episode 34: DAVE Trial: Targeted PRP With Anti-VEGF Therapy

Jonathan Prenner, MD, and Richard Kaiser, MD, sit down with David Brown, MD, to discuss the DAVE trial, a study in which researchers used targeted PRP in combination with anti-VEGF therapies in patients with DME. Dr. Brown outlines whether the trial showed that combination therapy decreased patients’ treatment burden compared with anti-VEGF monotherapy.


21 / 54 Series: Retina Today Journal Club


More Videos in this Series